Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results.
Jason BacharachDavid L WirtaRobert Smyth-MedinaMichael S KorenfeldShane R KannarrShane FosterMark J JarosCharles B SlonimPublished in: Clinical ophthalmology (Auckland, N.Z.) (2021)
Oxymetazoline 0.1% provided rapid and sustained upper eyelid elevation. Together with data demonstrating superior visual field improvement and a favorable safety profile, this analysis supports oxymetazoline 0.1% as an effective non-surgical treatment for acquired ptosis.